-
Product Insights
Gouty Arthritis (Gout): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Gouty Arthritis (Gout) - Global Clinical Trials Review, 2025" provides an overview of Gouty Arthritis (Gout) Clinical trials scenario. This report provides top line data relating to the clinical trials on Gouty Arthritis (Gout). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Gout Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Gout Market Report Overview The gout market across the 7MM (the US, France, Germany, Italy, Spain, the UK, and Japan) was valued at $4.63 billion in 2022 and the market will grow at a CAGR of more than 9% from 2022 to 2032. The market growth is attributed to the entrance of novel urate-lowering therapy (ULTs) which will increase the treatment options for more challenging and severe types of gout. This, in turn, will also accelerate the patient pool. The...
-
Product Insights
Gouty Arthritis (Gout) - Drugs In Development, 2024
Empower your strategies with our Gouty Arthritis (Gout) – Drugs In Development, 2024 report and make more profitable business decisions. Gout is a type of arthritis where swelling and severe pain develops in joints, especially at the base of the big toe. Gout occurs when uric acid builds up in the blood and causes inflammation in the joints. Symptoms include sudden onset of joint pain, joint swelling, heat in the affected area, and joint redness. Risk factors include obesity, high alcohol...
-
Sector Analysis
Gouty Arthritis (Gout) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Gout is a type of inflammatory arthritis that is triggered by the crystallization of uric acid within the joints. It is associated with hyperuricemia, often because of the overproduction or underexcretion of uric acid by the body. Uric acid is the product of the metabolism of purine-containing compounds, such as deoxyribonucleic acid and ribonucleic acid. Uric acid is a weak acid and exists largely in the form of a urate anion (an ionized form of uric acid) at the physiologic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.